Stockholders’ Equity (Deficit) - Stock-in-lieu of Cash Program Activity (Details)	12 Months Ended
	Dec. 31, 2023 $ / shares shares
Shares
Outstanding at beginning of period (in shares) | shares	8,162,850
Outstanding at end of period (in shares) | shares	6,199,453
Weighted Average Grant Date Fair Value per Share
Outstanding as of Beginning Balance (in dollars per share) | $ / shares	$ 1.74
Outstanding as of Ending Balance (in dollars per share) | $ / shares	$ 1.76
Vendor stock-in-lieu of cash program
Shares
Outstanding at beginning of period (in shares) | shares	1,047,151
Granted (in shares) | shares	15,281,701
Vested (in shares) | shares	(15,450,792)
Outstanding at end of period (in shares) | shares	878,060
Weighted Average Grant Date Fair Value per Share
Outstanding as of Beginning Balance (in dollars per share) | $ / shares	$ 11.90
Granted (in dollars per share) | $ / shares	4.34
Vested (in dollars per share) | $ / shares	4.86
Outstanding as of Ending Balance (in dollars per share) | $ / shares	$ 4.32